Terms: = Breast cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Prognosis
24 results:
1. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
2. Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer.
Rommasi F
Sci Rep; 2023 May; 13(1):8447. PubMed ID: 37231064
[TBL] [Abstract] [Full Text] [Related]
3. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer: are long-term and intermittent endocrine therapies equally effective?
Engel J; Schubert-Fritschle G; Emeny R; Hölzel D
J Cancer Res Clin Oncol; 2020 Aug; 146(8):2041-2049. PubMed ID: 32472445
[TBL] [Abstract] [Full Text] [Related]
5. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract] [Full Text] [Related]
6. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Tanoue K; Iino S; Kawasaki Y; Idichi T; Arigami T; Mori S; Shinden Y; Higashi M; Ueno S; Shinchi H; Natsugoe S
Pancreatology; 2020 Jan; 20(1):89-94. PubMed ID: 31787525
[TBL] [Abstract] [Full Text] [Related]
7. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract] [Full Text] [Related]
8. Determinants of breast cancer early detection for cues to expanded control and care: the lived experiences among women from Western Kenya.
Kisiangani J; Baliddawa J; Marinda P; Mabeya H; Choge JK; Adino EO; Khayeka-Wandabwa C
BMC Womens Health; 2018 Jun; 18(1):81. PubMed ID: 29859095
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BA; Rakha EA; Nolan CC; Ellis IO; Green AR
Pathol Res Pract; 2017 Jan; 213(1):27-33. PubMed ID: 27914769
[TBL] [Abstract] [Full Text] [Related]
10. Extremely rare presentation of soft tissue metastasis from carcinoma breast as a massive swelling of upper extremity.
Purkayastha A; Sharma N
Ann Palliat Med; 2016 Apr; 5(2):145-8. PubMed ID: 27121743
[TBL] [Abstract] [Full Text] [Related]
11. DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.
Khakpour G; Pooladi A; Izadi P; Noruzinia M; Tavakkoly Bazzaz J
Tumour Biol; 2015 Jul; 36(7):4905-12. PubMed ID: 26076810
[TBL] [Abstract] [Full Text] [Related]
12. Warranting investigation of primary lung adenocarcinoma in patients with an extrapulmonary malignancy and lung nodules due to high frequency.
Zhu B; Dalal S; Kamp DW; Lin X
Am J Clin Pathol; 2014 Mar; 141(3):429-36. PubMed ID: 24515772
[TBL] [Abstract] [Full Text] [Related]
13. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract] [Full Text] [Related]
14. Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression.
Semesiuk NI; Zhylchuk A; Bezdenezhnykh N; Lykhova A; Vorontsova AL; Zhylchuk VE; Kudryavets YI
Exp Oncol; 2013 Dec; 35(4):295-302. PubMed ID: 24382441
[TBL] [Abstract] [Full Text] [Related]
15. Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung.
Holzer TR; Fulford AD; Nedderman DM; Umberger TS; Hozak RR; Joshi A; Melemed SA; Benjamin LE; Plowman GD; Schade AE; Ackermann BL; Konrad RJ; Nasir A
PLoS One; 2013; 8(11):e80292. PubMed ID: 24244672
[TBL] [Abstract] [Full Text] [Related]
16. Role of treatment for solitary pulmonary nodule in breast cancer patients.
Kitada M; Sato K; Matsuda Y; Hayashi S; Miyokawa N; Sasajima T
World J Surg Oncol; 2011 Oct; 9():124. PubMed ID: 21989021
[TBL] [Abstract] [Full Text] [Related]
17. Proteomics approaches: new technologies and clinical applications in breast carcinomas.
Hamrita B; Nasr HB; Chahed K; Chouchane L
Gulf J Oncolog; 2011 Jan; (9):36-44. PubMed ID: 21177207
[TBL] [Abstract] [Full Text] [Related]
18. A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers.
Parra-Palau JL; Pedersen K; Peg V; Scaltriti M; Angelini PD; Escorihuela M; Mancilla S; Sánchez Pla A; Ramón Y Cajal S; Baselga J; Arribas J
Cancer Res; 2010 Nov; 70(21):8537-46. PubMed ID: 20978202
[TBL] [Abstract] [Full Text] [Related]
19. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall.
Cangelosi JJ; Nash JW; Prieto VG; Ivan D
Am J Dermatopathol; 2009 May; 31(3):278-81. PubMed ID: 19384070
[TBL] [Abstract] [Full Text] [Related]
20. [Bisphosphonate-associated osteonecrosis of the jaw].
Krauth MT; Fügl A; Gruber R
Wien Klin Wochenschr; 2008; 120(15-16):467-76. PubMed ID: 18820850
[TBL] [Abstract] [Full Text] [Related]
[Next]
